Share Name Share Symbol Market Type Share ISIN Share Description
Carclo Plc LSE:CAR London Ordinary Share GB0001751915 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 10.70p 10.60p 10.80p - - - 0 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 146.2 8.2 11.6 0.9 8

Carclo Share Discussion Threads

Showing 17551 to 17570 of 18175 messages
Chat Pages: Latest  703  702  701  700  699  698  697  696  695  694  693  692  Older
DateSubjectAuthorDiscuss
09/5/2018
08:46
Full Year Results due 5th June.
nick rubens
24/4/2018
13:43
A nice 10k buy at 100p has taken the share price above 100p now.
rivaldo
20/4/2018
11:52
I'm no longer invested here but have in the past. Much was made in the past of a relationship with a medication inhalation device of which I was skeptical because of trends in prescribing which would make that product a new entrant amongst several others in a declining market(I work in a related field). This time the agreement to make disposable insulin pens for BD for use with biosimilar insulin looks like a much more interesting proposition. I'm out because of the missed forecasts and pension shortfall. Paul
re1dy
20/4/2018
09:07
Fair enough Rivaldo, I agree that's what should happen.
queeny2
20/4/2018
08:46
Isn't anyone capable of talking their own book without distorting reality ? 80-100p was clearly a trading recovery buy, not a trend. There is nothing to support a trend based on CAR itself.
yump
20/4/2018
08:13
Good comments Rivaldo. I have one quibble, which is that I'm not clear they will meet analyst revised forecasts, all we can say for sure is that they confirmed the previous statement, which was 'substantially below' market forecasts and previous board expectations. If they've guided analysts to what they thought they would do, then fine, but the whole tone of the main warning statement, and sacking of FD, indicated to me that they (new chair) weren't at all certain about the scale of it. The one 'promise' they made was that the year just started would be better than they one just ended, which might even reinforce conservative treatment of y/e 3/18. But I could easily be wrong.
queeny2
20/4/2018
07:51
Just for the record, I got back in last week following a long time out. Debt still a concern for me. G.
garth
20/4/2018
07:37
:o)) CAR have moved up from 80p to almost 100p in the last 2 months. If all goes well that's just the start of the uptrend.
rivaldo
20/4/2018
07:29
Uptrend ??!!
yump
19/4/2018
16:50
The reality is this, if you actually look at the eps over a sensible period, rather than just picking out the ones that look ok, you get a different picture: 5.5 -33.2 3.3 11.5 9.2 11.2 I admit to selling out. The only reason being that they talked of good year on year increase, referring to the 'rise' from 9.2p to 11.2p. That was the last straw for me, seeing as I (and the forecasters) were expecting a rise from 11.5. There is no earthly reason for this to be on anything more than a p/e of 10 and given other businesses are on p/e's of only 12-15 and growing fairly reliably, imo 10 is pushing it a lot.
yump
19/4/2018
08:17
It's a vacuum until results in early June. Can go anywhere until that news.
queeny2
18/4/2018
11:14
Nice surge over 100p now, caused by 21,000 of buys at around 98p. Could be an indication of not much stock around.
rivaldo
17/4/2018
08:51
Edison's latest forecasts are now for historic 9.2p EPS, with 11.2p for this year - and a 3.9p dividend. And a rather impressive new FD appointment today, with a good track record: Https://www.investegate.co.uk/carclo-plc--car-/rns/directorate-change/201804170700070914L/
rivaldo
12/4/2018
10:01
Good spot - apologies, the news is coming too fast for me :o)) Nice to see the share price up 3p today to 94p mid-price (the thread header chart is hopelessly behind the times as usual).
rivaldo
12/4/2018
09:44
Rivaldo, didn’t you post that at 751?
pldazzle
12/4/2018
07:25
More expansion news not posted here before, this time in Bangalore, following the recent opening of the additional UK facility in Surrey: Http://www.carclo-ctp.co.uk/media-centre/press-releases/23-03-2018.aspx "Bangalore facility expansion 23 Mar 2018 LONDON, 23 March 2018. Carclo Technical Plastics Ltd (CTP) announces that it has expanded its manufacturing facility in Doddaballapur near Bangalore, India, enabling it to continue serving existing customers in the electronics industry and target the growing local medical market. CTP’s facility is accredited to ISO 9001 (ISO13485 pending) and has a capacity for approximately 40 injection moulding machines plus assembly capability. Key to the expansion is a new medical hall, equipped with state-of-the-art, all-electric injection moulding machines from leading supplier Fanuc. CTP has invested in new manufacturing space, injection moulding machines, ancillaries and specialist staff in Bangalore as it targets medical customers in the region. The expansion also provides significant scope for growth. CTP India Managing Director Gary Allan stated “Carclo Technical Plastics was initially established in Bangalore in 2007 with support from Suprajit Engineering, a long term partner of Carclo. This was followed by construction of a new, purpose-built operation in the same location in 2010. The business has built a strong reputation for high quality, reliable supply and customer service. CTP’s global facilities have long been involved in manufacture of disposable diagnostic and delivery devices and we are delighted to be expanding our facility in Bangalore and targeting medical plastic component opportunities in India.” Carclo Technical Plastics, www.carclo-ctp.co.uk, is the largest division within Carclo plc with manufacturing operations in the UK, East and West USA, Czech Republic, India and China. The business increasingly adds value to its customers by assembling and packaging finished devices for the medical, pharmaceutical, diagnostic and ophthalmic sectors. Typical products include drug delivery devices such as injection devices and asthma inhalers and diagnostic consumables such as pipette tips, reagent packs and Point-of-Care cartridges."
rivaldo
11/4/2018
09:27
Peel Hunt retain their Buy and 130p target for CAR - 45% upside from here: http://investing.thisismoney.co.uk/broker-views/index/date/10-04-2018 CAR have now definitively stated that their results for last year will be in line with expectations. I note that Peel Hunt have retained their forecasts of historic 8.95p EPS, with 10.92p EPS forecast for this year - a P/E of only 8. Peel Hunt also have the dividend being reinstated at 2p. Incidentally, that would imply CAR achieved 4.45p EPS in the last H2 despite the order delays etc. Which bodes rather well for the current year. In addition, Peel Hunt's forecast is the lowest in the market - for example, Edison go for 11.2p EPS, Finncap 11.1p EPS and Equity Development 11.4p EPS.
rivaldo
10/4/2018
16:58
I can see both sides of the argument.If they can match H1 and do 9p of earnings that would be a good result. It's not clear to me that they will, but who knows.The bear case is in these two excerpts from the warning:"In addition, as a consequence of some of these delayed projects and lower customer orders, the Board has now reduced its profit expectations for the 2018/19 financial year" ..... lower customer orders, not just delays"In view of the disappointing reduction in anticipated profitability for the current year, a more fundamental and urgent review of operating efficiencies and margins at this division is to be undertaken." ..... the new chair is not at all happy with CTP underlying economics on existing business. Can he fix that with operating efficiencies? Or is it just a low margin business.If he can steady the ship, and return to any sort of growth, then absent the pension and debt it looks fine, even cheap.
queeny2
09/4/2018
09:51
CAR was a different company in those days as a blue sky speculative stock with good core businesses which didn't come off. Now it's a (relatively!) solid and very profitable stock - on a P/E of 7.9 - with good recurring income and niche specialisms with high barriers to entry. The earlier trading statement noted in LEDs "the previously awarded mid-volume programmes commence production from 2019", and re CTP "the new medical programmes won in Technical Plastics are expected to underpin good growth in this division". With the additional delayed work from the year to March'18, I suspect this year and next year could go rather well assuming stable markets. The core businesses have been consistently and extremely profitable - see the thread header post - with just the one blip last year. I believe this core business will continue to show good global growth.
rivaldo
09/4/2018
08:51
Yes it's cheap but with the track record of this management who would want to buy the shares. From near 500p to 80p is some achievement. Their customers seem to hold the whip hand on pricing.
meijiman
Chat Pages: Latest  703  702  701  700  699  698  697  696  695  694  693  692  Older
Your Recent History
LSE
CAR
Carclo
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191018 03:45:47